Miao-Miao Niu

发表

A Redox‐Triggered Bispecific Supramolecular Nanomedicine Based on Peptide Self‐Assembly for High‐Efficacy and Low‐Toxic Cancer Therapy

Bin Di, Da-song Yang, Yin-He Yang, 2019, Advanced Functional Materials.

Augmenting the Precise Targeting of Antimicrobial Peptides (AMPs) and AMP‐Based Drug Delivery via Affinity‐Filtering Strategy

Jinjin Shi, Zhang-bao Chen, Yang Yu, 2022, Advanced Functional Materials.

Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.

Bin Di, Cheng Jiang, Tongyuan Lin, 2018, Bioorganic & medicinal chemistry.

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy

Yunjiang Zhou, Miao-Miao Niu, Yang Yang, 2022, Frontiers in Pharmacology.

Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections

Tong Yan, Kexin Huang, Miao-Miao Niu, 2021, Acta pharmaceutica Sinica. B.

Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection

S. Jiang, Miao-Miao Niu, Jindong Li, 2022, Frontiers in Pharmacology.

Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75

Xiujuan Chen, Zhiqin Li, Miao-Miao Niu, 2022, Frontiers in Pharmacology.

Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain

Xiaoyun Fu, Miao-Miao Niu, Fang Yan, 2019, Molecules.

Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer.

Yunjiang Zhou, Miao-Miao Niu, Mei Yang, 2022, Journal of the American Chemical Society.

Design and synthesis of an immobilized metal affinity chromatography and metal oxide affinity chromatography hybrid material for improved phosphopeptide enrichment.

Bin Di, Mengxiang Su, Da-song Yang, 2017, Journal of chromatography. A.

Discovery of a Potent PLK1-PBD Small-Molecule Inhibitor as an Anticancer Drug Candidate through Structure-Based Design

Yunjiang Zhou, Miao-Miao Niu, Fang Yan, 2019, Molecules.

Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking

Haiyan Chen, Caiping Tian, Guissi Fida, 2014, Acta Pharmacologica Sinica.

Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation.

Ren Ren, Bin Di, Xiaolian Sun, 2021, Journal of medicinal chemistry.

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors

Yunjiang Zhou, Miao-Miao Niu, Tingting Chen, 2019, Molecules.

Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity

Bin Di, Yunjiang Zhou, Miao-Miao Niu, 2019, Molecules.

A Supramolecular Nanomedicine Based on Bendamustine and MDM2‐Targeted D‐peptide Inhibitor for Breast Cancer Therapy

Xing Huang, Chong Li, Yunjiang Zhou, 2021, Advanced healthcare materials.

Association between serum uric acid and carotid atherosclerosis in elderly postmenopausal women: A hospital‐based study

Miao-Miao Niu, Wenjun Chen, D. Luo, 2021, Journal of clinical laboratory analysis.

Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation

Yonghua Xu, Miao-Miao Niu, Zhen Xu, 2023, Journal of enzyme inhibition and medicinal chemistry.

Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents

Miao-Miao Niu, L. Yang, Yan Zhang, 2023, Journal of enzyme inhibition and medicinal chemistry.

Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation

Yangli Zhou, Miao-Miao Niu, Hai Zhang, 2022, Frontiers in Pharmacology.

Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies

Miao-Miao Niu, Ting Guo, Chun-ji Hu, 2023, Journal of enzyme inhibition and medicinal chemistry.

Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity

Miao-Miao Niu, Yingxue Yang, Shutong Chen, 2023, Frontiers in pharmacology.

An NRP1/MDM2‐Targeted D‐Peptide Supramolecular Nanomedicine for High‐Efficacy and Low‐Toxic Liver Cancer Therapy

Yunjiang Zhou, Miao-Miao Niu, Yingying Tan, 2021, Advanced Healthcare Materials.

Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation

Miao-Miao Niu, Xiao Qiao, Xiangyu Wu, 2023, Journal of enzyme inhibition and medicinal chemistry.

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection.

Miao-Miao Niu, Kai Yuan, Yunting Zou, 2023, European journal of medicinal chemistry.

Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations.

Qiaoxuan Zhang, Miao-Miao Niu, Xing Jin, 2023, Journal of enzyme inhibition and medicinal chemistry.

Discovery of a dual-target DYRK2 and HDAC8 inhibitor for the treatment of hepatocellular carcinoma.

Miao-Miao Niu, Yuting Wang, Li Zhang, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.